Plant Comparison
Boswellia vs Hemp
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Boswellia and Hemp: they share 6 indicated uses (arthritis / joint pain, back pain, headache, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Boswellia | Hemp | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 9/10 | 5/10 | Stronger for Boswellia |
| Back pain | 7/10 | 5/10 | Stronger for Boswellia |
| Headache | 7/10 | 5/10 | Stronger for Boswellia |
| Inflammation (general) | 5/10 | 5/10 | Comparable evidence |
| Pain (general) | 9/10 | 5/10 | Stronger for Boswellia |
| Skin irritation | 5/10 | 5/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal anti-inflammatory compounds; AKBA inhibits 5-lipoxygenase. Absorption improves when taken with a high-fat meal.
Additional constituents of the oleo-gum-resin.
The characteristic bioactive compounds of the resin-bearing flowers, varying widely in ratio and concentration between cultivars; THC is psychoactive, CBD is not.
Aromatic terpenes contribute to the plant's characteristic scent and may modulate cannabinoid effects.
Hemp seed is rich in polyunsaturated fatty acids (including omega-3 and omega-6), giving the pressed seed oil its nutritional value; essentially free of psychoactive cannabinoids.
Pharmacological Actions
Anti-inflammatory (inhibits 5-lipoxygenase / leukotriene synthesis and NF-kB signalling); Reduces inflammatory markers (e.g. hs-CRP) and, in one RCT, improved knee joint-space and reduced osteophytes on radiograph
Boswellic acids, especially acetyl-11-keto-beta-boswellic acid (AKBA) from Boswellia serrata, induce cell-cycle arrest and apoptosis and inhibit proliferation, invasion and metastasis across lung, colorectal and prostate cancers (preclinical, incl. in vivo).
Traditional & Indicated Uses
Osteoarthritis: reduces joint pain and stiffness and improves function (over at least 4 weeks); Supports inflammatory arthritis including rheumatoid arthritis
Boswellia serrata resin and its triterpenoid AKBA arrest the cell cycle and induce apoptosis in non-small-cell lung cancer, suppress colitis-associated colorectal cancer (NF-kB, gut microbiota) and inhibit prostate cancer (IL-17 pathway) in vitro and in vivo (preclinical).
Supportive in inflammatory bowel disease (ulcerative colitis, Crohn's disease)
inferred from anti-inflammatory action
Analgesic (pain relief); Osteoarthritis: reduces joint pain and stiffness and improves function (over at least 4 weeks)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
Safety, Cautions & Contraindications
Generally well tolerated; the most commonly reported side effects are mild gastrointestinal symptoms, and allergic reactions are rare.
Boswellic acids can affect drug-metabolising enzymes, so caution is advised when taking other medicines; safety in pregnancy and breastfeeding is not established, so avoid medicinal doses.
Industrial hemp (low-THC cannabis) seed oil and seeds are generally safe as food. CBD products derived from hemp may interact with medications metabolised by cytochrome P450 liver enzymes, including common anticoagulants, antiepileptics, and immunosuppressants. THC-containing preparations impair driving and are regulated or prohibited in many jurisdictions. Not recommended during pregnancy or breastfeeding. Quality and cannabinoid content vary widely between hemp products.
Duke (2002) rates cannabis as ++ and notes clinical evidence (score 2) for its antiemetic activity, especially relevant for chemotherapy-induced nausea. Score 1 activities include analgesic, anticonvulsant, and anti-inflammatory properties. Duke highlights the legal and pharmacological complexity, noting THC as the primary psychoactive compound. Medically, synthetic cannabinoids (dronabinol, nabilone) are clinically approved for nausea and anorexia. Duke cautions that while the plant has genuine therapeutic potential, psychoactive effects, legal restrictions, and risk of dependence with regular use must be considered (Duke, 2002).
External Ids
Botanical Description
Small to medium deciduous tree with thin, papery, peeling bark. The leaves are pinnately compound with numerous small, toothed leaflets, clustered toward the branch tips. Small, pale yellow to white flowers are borne in axillary racemes. When the bark is cut, it exudes a fragrant, resinous gum (oleo-gum-resin) that hardens into pale, waxy tears - the medicinal part.[12]
Erect annual herb with a distinctive palmately compound leaf of narrow, serrated leaflets. The plant is usually dioecious (separate male and female plants); female plants develop dense, resinous flower clusters, while male plants bear looser pollen-releasing flowers. The seed (achene) is small, hard-shelled and oil-rich.[14]
Habitat
Native to dry, rocky, hilly terrain of India and parts of the Middle East and North Africa, where it is tapped for its resin much like frankincense (Boswellia sacra).[12]
Believed native to Central Asia; now cultivated worldwide, with industrial hemp (low-THC cultivars) grown in temperate climates for fibre, seed and cannabinoid extraction, subject to varying legal regulation by jurisdiction.[14]
Harvesting
The bark is deliberately incised and the exuded oleo-gum-resin is allowed to harden and is collected over several days to weeks, then cleaned and graded before use or extraction.[12]
Flowers (and resin-bearing leaves) are harvested at peak resin/cannabinoid content, typically as the flower clusters mature in late summer to autumn; seed is harvested once mature and dried, then pressed for oil or used whole.[14]
Traditional Uses
Boswellia resin (salai guggul) is a mainstay of Ayurvedic medicine for inflammatory joint and respiratory conditions, and has been burned as incense across many cultures. Modern standardised extracts, rich in boswellic acids, are used for osteoarthritis, inflammatory bowel disease and other inflammatory conditions, directly building on this traditional anti-inflammatory reputation.[12]
Cannabis/hemp has a long multi-cultural history as a fibre, food and medicinal plant, traditionally used for pain, muscle spasm, sleep and appetite, alongside industrial use of the fibre and seed. Modern cannabinoid research, particularly on THC and CBD, has substantially expanded the evidence base for pain, spasticity and specific seizure disorders.[14, 15]
Preparations
Resin extract standardised to boswellic acid (often AKBA) content, taken as capsules or tablets, ideally with a fat-containing meal to aid absorption.
Whole or hulled seed, or cold-pressed seed oil, used as a nutritional food source (essentially free of psychoactive cannabinoids).
Extract standardised to specific cannabinoid content (e.g. CBD), used in regulated medicinal products; regulatory status varies widely by jurisdiction and product type.
Dosage
Clinical trials in osteoarthritis commonly use extracts providing around 100-250 mg of boswellic acids (or several hundred mg of standardised extract) daily, in divided doses, taken with food. Educational reference only, not a prescription.
Not documented
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Siddiqui, M.Z (2011) 'Boswellia serrata, a potential antiinflammatory agent: an overview', Indian Journal of Pharmaceutical Sciences, 73(3), pp. 255-261. doi:10.4103/0250-474X.93507 Meta-analysis / review
https://doi.org/10.4103/0250-474X.93507 - Majeed, M., Majeed, S., Narayanan, N.K. and Nagabhushanam, K (2019) 'A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee', Phytotherapy Research, 33(5), pp. 1457--1468. doi:10.1002/ptr.6338 Randomized trial
https://doi.org/10.1002/ptr.6338 - Karlapudi, V., Sunkara, K.B., Konda, P.R., Sarma, K.V. and Rokkam, M.P (2022) 'Efficacy and Safety of Aflapin, a Novel Boswellia serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study', Journal of the American Nutrition Association, 42(2), pp. 159-168. doi:10.1080/07315724.2021.2014370 Randomized trial
https://doi.org/10.1080/07315724.2021.2014370 - Kirste, S., Treier, M., Wehrle, S.J., Becker, G., Abdel-Tawab, M., Gerbeth, K., Hug, M.J., Lubrich, B., Grosu, A.L. and Momm, F (2011) 'Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial', Cancer, 117(16), pp. 3788-3795. doi:10.1002/cncr.25945 Randomized trial
https://doi.org/10.1002/cncr.25945 - Abdel-Tawab, M., Werz, O. and Schubert-Zsilavecz, M (2011) 'Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data', Clinical Pharmacokinetics, 50(6), pp. 349-369. doi:10.2165/11586800-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11586800-000000000-00000 - Gomaa, A.A., Mohamed, H.S., Abd-Ellatief, R.B. and Gomaa, M.A (2021) 'Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly', Inflammopharmacology, 29(4), pp. 1033-1048. doi:10.1007/s10787-021-00841-8 Meta-analysis / review
https://doi.org/10.1007/s10787-021-00841-8 - Khan, M.A., Ali, R., Parveen, R., Najmi, A.K. and Ahmad, S (2016) 'Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrata', Journal of Ethnopharmacology, 191, pp. 315-323. doi:10.1016/j.jep.2016.06.053 Meta-analysis / review
https://doi.org/10.1016/j.jep.2016.06.053 - Ammon, H.P.T (2010) 'Modulation of the immune system by Boswellia serrata extracts and boswellic acids', Phytomedicine, 17(11), pp. 862-867. doi:10.1016/j.phymed.2010.03.003 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2010.03.003 - Alluri, V.K., Kundimi, S., Sengupta, K., Golakoti, T. and Kilari, E.K (2020) 'An Anti-Inflammatory Composition of Boswellia serrata Resin Extracts Alleviates Pain and Protects Cartilage in Monoiodoacetate-Induced Osteoarthritis in Rats', Evidence-Based Complementary and Alternative Medicine, 2020, pp. 7381625. doi:10.1155/2020/7381625 Preclinical
https://doi.org/10.1155/2020/7381625 - Henrotin, Y., Dierckxsens, Y., Delisse, G., Maes, N. and Albert, A (2022) 'Curcuma and Boswellia serrata extract combination for hand osteoarthritis: an open-label pre-post trial', Pharmaceutical Biology, 60(1), pp. 2295-2299. doi:10.1080/13880209.2022.2147550 Clinical study
https://doi.org/10.1080/13880209.2022.2147550 - Cherepanova, M.O. and Subotyalov, M.A (2023) 'Component Composition and Biological Activity of Oleo-Gum Resin from Boswellia serrata (Burseraceae)', Doklady Biological Sciences, 512(1), pp. 336-342. doi:10.1134/S0012496623700643 Meta-analysis / review
https://doi.org/10.1134/S0012496623700643 - Ammon, H.P.T (2016) 'Boswellic Acids and Their Role in Chronic Inflammatory Diseases', Advances in Experimental Medicine and Biology. doi:10.1007/978-3-319-41334-1_13 Preclinical
https://doi.org/10.1007/978-3-319-41334-1_13 - Yu, G., Xiang, W., Zhang, T., Zeng, L., Yang, K. and Li, J (2020) 'Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis', BMC Complementary Medicine and Therapies. doi:10.1186/s12906-020-02985-6 Meta-analysis / review
https://doi.org/10.1186/s12906-020-02985-6 - Lv, M. and Shao, S. and Zhang, Q. and Zhuang, X. and Qiao, T (2020) 'Acetyl-11-Keto-beta-Boswellic Acid Exerts the Anti-Cancer Effects via Cell Cycle Arrest, Apoptosis Induction and Autophagy Suppression in Non-Small Cell Lung Cancer Cells', OncoTargets and Therapy, 13, pp. 733-744. doi:10.2147/OTT.S236346 Preclinical
https://doi.org/10.2147/OTT.S236346 - Xu, F. and Li, W. and Zheng, X.-J. and Hao, Y. and Yang, Y.-H. and Yang, H. and Zhang, S. and Cao, W.-X. and Li, X.-X. and Zhang, X. and Du, G.-H. and Ji, T.-F. and Wang, J.-H (2025) '3-O-Acetyl-11-Keto-beta-Boswellic Acid Suppresses Colitis-Associated Colorectal Cancer by Inhibiting the NF-kB Signaling Pathway and Remodeling Gut Microbiota', Oncology Research, 33(8), pp. 1969-1989. doi:10.32604/or.2025.062386 Preclinical
https://doi.org/10.32604/or.2025.062386 - Zou, B. and Liu, Q. and Long, Y. and Dai, X. and Tian, X. and Zhou, Q (2025) 'Network Pharmacology Combined with Proteomics Reveals That 3-Acetyl-11-keto-beta-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway', ACS Omega, 10(21), pp. 21813-21822. doi:10.1021/acsomega.5c01683 Preclinical
https://doi.org/10.1021/acsomega.5c01683 - Ragab, E.A. and Abd El-Wahab, M.F. and Doghish, A.S. and Salama, R.M. and Eissa, N. and Darwish, S.F (2023) 'The journey of boswellic acids from synthesis to pharmacological activities', Naunyn-Schmiedeberg's Archives of Pharmacology, 397(3), pp. 1477-1504. doi:10.1007/s00210-023-02725-w Preclinical
https://doi.org/10.1007/s00210-023-02725-w - Liu, X., Machado, G.C., Eyles, J.P., Ravi, V. and Hunter, D.J (2018) 'Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis', British Journal of Sports Medicine, 52(3), pp. 167--175. doi:10.1136/bjsports-2016-097333 Meta-analysis / review
https://doi.org/10.1136/bjsports-2016-097333
- Rock, E.M. and Parker, L.A (2021) 'Constituents of Cannabis sativa', Advances in Experimental Medicine and Biology, 1264, pp. 1-13. doi:10.1007/978-3-030-57369-0_1 Traditional / reference
https://doi.org/10.1007/978-3-030-57369-0_1 - Castillo-Arellano, J., Canseco-Alba, A., Cutler, S.J. and León, F (2023) 'The Polypharmacological Effects of Cannabidiol', Molecules, 28(7), pp. 3271. doi:10.3390/molecules28073271 Traditional / reference
https://doi.org/10.3390/molecules28073271 - Pagano, C., Navarra, G., Coppola, L., Avilia, G. et al (2022) 'Cannabinoids: Therapeutic Use in Clinical Practice', International Journal of Molecular Sciences, 23(6), pp. 3344. doi:10.3390/ijms23063344 Traditional / reference
https://doi.org/10.3390/ijms23063344 - ElSohly, M.A., Radwan, M.M., Gul, W., Chandra, S. and Galal, A (2017) 'Phytochemistry of Cannabis sativa L', Progress in the Chemistry of Organic Natural Products, 103, pp. 1-36. doi:10.1007/978-3-319-45541-9_1 Meta-analysis / review
https://doi.org/10.1007/978-3-319-45541-9_1 - Viana, M.D.B., de Aquino, P.E.A., Estadella, D., Ribeiro, D.A. and Viana, G.S.D.B (2022) 'Cannabis sativa and cannabidiol: a therapeutic strategy for the treatment of neurodegenerative diseases?', Medical Cannabis and Cannabinoids, 5(1), pp. 207-219. doi:10.1159/000527335 Meta-analysis / review
https://doi.org/10.1159/000527335 - Alves, P., Amaral, C., Teixeira, N. and Correia-da-Silva, G (2020) 'Cannabis sativa: much more beyond delta-9-tetrahydrocannabinol', Pharmacological Research, 157, pp. 104822. doi:10.1016/j.phrs.2020.104822 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.104822 - Odieka, A.E., Obuzor, G.U., Oyedeji, O.O., Gondwe, M., Hosu, Y.S. and Oyedeji, A.O (2022) 'The medicinal natural products of Cannabis sativa Linn.: a review', Molecules, 27(5), pp. 1689. doi:10.3390/molecules27051689 Meta-analysis / review
https://doi.org/10.3390/molecules27051689 - Nuutinen, T (2018) 'Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus', European Journal of Medicinal Chemistry, 157, pp. 198-228. doi:10.1016/j.ejmech.2018.07.076 Meta-analysis / review
https://doi.org/10.1016/j.ejmech.2018.07.076 - Liktor-Busa, E., Keresztes, A., LaVigne, J., Streicher, J.M. and Largent-Milnes, T.M (2021) 'Analgesic potential of terpenes derived from Cannabis sativa', Pharmacological Reviews, 73(4), pp. 98-126. doi:10.1124/pharmrev.120.000046 Meta-analysis / review
https://doi.org/10.1124/pharmrev.120.000046 - Martinelli, G., Magnavacca, A., Fumagalli, M., Dell'Agli, M., Piazza, S. and Sangiovanni, E (2021) 'Cannabis sativa and skin health: dissecting the role of phytocannabinoids', Planta Medica, 88(7), pp. 492-506. doi:10.1055/a-1420-5780 Meta-analysis / review
https://doi.org/10.1055/a-1420-5780 - Andre, C.M., Hausman, J.F. and Guerriero, G (2016) 'Cannabis sativa: the plant of the thousand and one molecules', Frontiers in Plant Science, 7, pp. 19. doi:10.3389/fpls.2016.00019 Meta-analysis / review
https://doi.org/10.3389/fpls.2016.00019 - Bonini, S.A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M. and Mastinu, A (2018) 'Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history', Journal of Ethnopharmacology, 227, pp. 300-315. doi:10.1016/j.jep.2018.09.004 Meta-analysis / review
https://doi.org/10.1016/j.jep.2018.09.004 - Bergamaschi, M.M., Queiroz, R.H.C., Zuardi, A.W. and Crippa, J.A.S (2011) 'Safety and side effects of cannabidiol, a Cannabis sativa constituent', Current Drug Safety, 6(4), pp. 237-249. doi:10.2174/157488611798280924 Meta-analysis / review
https://doi.org/10.2174/157488611798280924 - Cerino, P., Buonerba, C., Cannazza, G. et al (2021) 'A review of hemp as food and nutritional supplement', 6(1), pp. 19--27. doi:10.1089/can.2020.0001 Preclinical
https://doi.org/10.1089/can.2020.0001 - Devinsky, O., Cross, J.H., Laux, L. et al (2017) 'Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome', 376(21), pp. 2011--2020. Randomized trial
https://scholar.google.com/scholar?q=Trial%20of%20cannabidiol%20for%20drug-resistant%20seizures%20in%20the%20Dravet%20syndrome - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talwar, A., Estes, E., Aparasu, R. and Reddy, D.S (2022) 'Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis', Experimental Neurology, 359, pp. 114238. doi:10.1016/j.expneurol.2022.114238 Meta-analysis / review
https://doi.org/10.1016/j.expneurol.2022.114238 - Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
https://doi.org/10.3390/ph19030399
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.